Time is running out for passage of additional US fiscal stimulus in 2020 as the year winds down and the holidays rapidly approach. Congressional parties hit a brick wall yet again, even with the scaled-down $900 billion plan, this time on conflict over employer virus liability. Each time the negotiations appear to be about to […]
December may normally be associated with everything slowing down as we ease our way into the festive period, but as with everything else in 2020, this is no normal December. Donald Trump is continuing to fight the election result and is going out swinging, Brexit talks are somehow still ongoing, the EU budget and rescue […]
COVID-19 is likely to remain the dominant market theme in the coming, holiday-shortened week. The rising trajectory of the pandemic versus ongoing progress toward a vaccine will cause investors to whipsaw wildly between pessimism and optimism, driving markets lower or higher depending on prevailing sentiment. Last week played out much as we predicted, when positive […]
On Saturday, the media called the US presidential election for Joe Biden, but President Donald Trump rejected the outcome and won’t concede. Additionally, he will continue with legal challenges, claiming fraud. So far, his demand made no progress in courts, as he failed to add prove to his accusations, except for those asking for observers […]
With the US presidential election coming closer, up for November 05, global banks come forward with their analysis concerning the most likely outcome if the market favorite Democrats win. Asian shares remain bid, led by China, while heading into the European open on Monday. Although weekend headlines challenged Friday’s optimism, mainly due to the chatters […]
Brexit talks and rising coronavirus cases in Europe are also a consideration for general market mood. The EU and UK resume negotiations this week and the risk of a no-deal Brexit is another shroud of uncertainty for the global economy. The focus will shift to the latest US non-farm payrolls report on Friday. Rosy data […]
The major central banks have met, and not one felt it incumbent upon them to take fresh policy action. Despite some dramatic intraday swings and close scrutiny, the euro-dollar exchange rate continues to be mainly in a $1.17-$1.19 trading range that has dominated since the end of July. All the commotion about the rapid rise […]
AstraZeneca’s renewal of its coronavirus vaccine test is contributing to a better market mood, favorable for stocks and weighing on the dollar. Japan will have a new prime minister and the UK parliament will debate the controversial internal market bill today, aggravating relations with the EU. Below are thumbnail sketches of the events and data […]
Investors are cheering fresh hopes for an upcoming coronavirus vaccine and upbeat Chinese PMIs. Eurozone CPI figures and end-of-month flows are set to move markets. Stephen Hahn, head of the US Food and Drug Administration, said he is willing to fast-track vaccine approval if benefits outweigh the risks. China has approved the Sinovac COVID-19 vaccine […]
